Chemoinformaics analysis of 2,4-OCTADIENAL, (E,Z)-
Molecular Weight | 124.183 | nRot | 4 |
Heavy Atom Molecular Weight | 112.087 | nRig | 3 |
Exact Molecular Weight | 124.089 | nRing | 0 |
Solubility: LogS | -1.305 | nHRing | 0 |
Solubility: LogP | 1.582 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 22.1635 |
nHD | 0 | BPOL | 12.9065 |
QED | 0.414 |
Synth | 3.374 |
Natural Product Likeliness | 2.499 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.003 |
HIA | 0.005 |
CACO-2 | -4.495 |
MDCK | 0.0000281 |
BBB | 0.981 |
PPB | 0.357913 |
VDSS | 1.081 |
FU | 0.552058 |
CYP1A2-inh | 0.109 |
CYP1A2-sub | 0.397 |
CYP2c19-inh | 0.035 |
CYP2c19-sub | 0.652 |
CYP2c9-inh | 0.007 |
CYP2c9-sub | 0.636 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.869 |
CYP3a4-inh | 0.016 |
CYP3a4-sub | 0.209 |
CL | 6.356 |
T12 | 0.744 |
hERG | 0.02 |
Ames | 0.911 |
ROA | 0.864 |
SkinSen | 0.98 |
Carcinogencity | 0.727 |
EI | 0.991 |
Respiratory | 0.952 |
NR-Aromatase | 0.424 |
Antiviral | No |
Prediction | 0.955486 |